Abstract:A recent large-scale metabolic analysis of 853 fungal strains from diverse phylogenies suggests that only ~10% of yeasts are metabolic specialists [2]. Within that grouping, only C . glabrata , which has recently been renamed to Nakaseomyces glabratus , is a human pathogen. This places C . glabrata in a unique position that runs counterintuitive to the Candida albicans paradigm that dynamic host microenvironments require rapid pathogen adaptation facilitated by metabolic generalism [3]. Limited data are available on C . glabrata metabolic adaptation within the host, leaving much to be learned about the metabolic factors necessary for its pathogenesis. Interestingly, Saccharomyces cerevisiae and C . albicans were classified as "Normal" in this metabolic analysis, narrowly missing the specialist and generalist classifications we would classically assign to each species. We are considering S . cerevisiae and C . albicans as examples of metabolic specialists and generalists for the purposes of this article. Candida species have evolved metabolic pathways and regulatory mechanisms to thrive in the human host environment, demonstrating remarkable resource range and adaptability. C . albicans is well-known for its metabolic flexibility and ability to metabolize a broad range of carbon sources including N-acetylglucosamine (GlcNAc), a monosaccharide derived from host glycoproteins and glycolipids. C . glabrata also exhibits significant adaptability to the host environment, albeit through different mechanisms due to its divergent evolutionary background. C . glabrata does not rely on GlcNAc as a primary carbon source but has instead developed alternative metabolic strategies to survive in nutrient-limited conditions. For instance, C . glabrata can efficiently utilise non-fermentable carbon sources such as glycerol, fatty acids, and amino acids, especially when glucose is scarce. This metabolic versatility allows C . glabrata to prosper in exigent host environments, such as the bloodstream, where glucose levels are high compared to most host niches (approximately 0.1%) [4], and low oxygen niches where other carbon sources are more prevalent. However, our knowledge around metabolic plasticity is limited to just a few strains per fungal species [5]. There is much better depth of understanding about intraspecies diversity in resource management and how this impacts colonisation and disease in bacterial pathogens, such as Salmonella [6]. Finally, metabolising or detoxifying host-derived compounds and the production of tissue-damaging enzymes is fundamental to Candida species' capacity to cause disease [7]. Proteases, such as secreted aspartyl proteases or yapsins [8], can support nutrient sensing or regulation, nutrient acquisition and contribute to host immune evasion and damage. Metabolism also influences host immune evasion and damage by contributing precursors to cell wall biosynthesis and regulating production of other virulence factors, like EPA adhesins. Further, glutathione and trehalose production serve a critically protective role against oxidative stressors, like those imposed by innate immune cells. Both glutathione and trehalose are involved in resistance to antifungal agents, and trehalose can also be used as a carbon storage system [9]. C . glabrata excels at managing oxidative stress, a critical factor for survival in the hostile host immune system environment and can withstand higher H 2 O 2 concentrations than even C . albicans [10].

Genetic Manipulation of Candida glabrata

Expanding the toolkit for genetic manipulation and discovery in Candida species using a CRISPR ribonucleoprotein-based approach

Molecular Genetic Techniques for Gene Manipulation in Candida Albicans.

Functional genetic characterization of stress tolerance and biofilm formation in Nakaseomyces (Candida) glabrata via a novel CRISPR activation system

Identification of Essential Genes and Fluconazole Susceptibility Genes in Candida glabrata by Profiling Hermes Transposon Insertions

Development and Verification of an FLP/FRT System for Gene Deletion in Candida Amazonensis

Biolistic Transformation of Cryptococcus neoformans

A CUG codon-adapted anchor-away toolkit for functional analysis of genes in Candida albicans

Gene Editing of Candida glycerinogenes by Designed Toxin-Antitoxin Cassette

Identification of Candida glabrata Transcriptional Regulators That Govern Stress Resistance and Virulence

Genetic modification of Candida maltosa, a non-pathogenic CTG species, reveals EFG1 function

Transient Mitochondria Dysfunction Confers Fungal Cross-Resistance against Phagocytic Killing and Fluconazole

Preparation and Purification of β-1,3-glucan-Linked Candida glabrata Cell Wall Proteases by Ion-Exchange Chromatography, Gel Filtration, and MDPF-Gelatin-Zymography Assay

Dramatic Improvement of CRISPR/Cas9 Editing in Candida albicans by Increased Single Guide RNA Expression

Precise genome editing underlines the distinct contributions of mutations in ERG11, ERG3, MRR1, and TAC1 genes to antifungal resistance in Candida parapsilosis

Genome-wide piggyBac transposon-based mutagenesis and quantitative insertion-site analysis in haploid Candida species

Tn-seq of the Candida glabrata reference strain CBS138 reveals epigenetic plasticity, structural variation, and intrinsic mechanisms of resistance to micafungin

Is metabolic generalism the Breakfast of Champions for pathogenic Candida species?

The regulatory subunits of CK2 complex mediate DNA damage response and virulence in Candida Glabrata

Genome‐wide profiling of piggyBac transposon insertion mutants reveals loss of the F1F0 ATPase complex causes fluconazole resistance in Candida glabrata

Development of an efficient genetic manipulation strategy for sequential gene disruption and expression of different heterologous GFP genes in Candida tropicalis